FDA Brief

Company record

Oasis Medical, Inc.

1 FDA warning letter since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Oasis Medical, Inc..

Warning letters

  1. Oasis Medical, Inc.

    FDA cites Oasis Medical for current good manufacturing practice violations in sterile ophthalmic drugs, including particulate contamination and unresolved sterility failures.

    High risk

Recalls

ReportedClassFirmProduct and reason
May 20 Class II Oasis Medical, Inc.
Drug
Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for: OASIS Medical, Inc., 514 S. Vermont Ave., Glendora, CA 91741, USA, Made in France, NDC 42126-6400-1.
Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision.